SCHEMBL24376263

SCHEMBL24376263

CCOC(=O)C1=C(C(F)(F)F)OC(O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALOX15 P16050 1/20 0.37
HDAC4 P56524 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35
GAA P10253 2/20 0.33
ADORA2B P29275 2/20 0.33
TP53 P04637 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
LMNA P02545 2/20 0.32
HIF1A Q16665 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24376720 0.76 KDM4E (0.36) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL9225568 0.69 HDAC4 (0.38) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL5608026 0.66 KDM4E (0.59) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL30032278 0.63 MAPT (0.40) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL11035853 0.63 KDM4E (0.61) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL20263547 0.63 KDM4E (0.49) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL234027 0.63 KDM4E (0.55) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL28283233 0.63 KDM4E (0.55) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL9548196 0.62 KDM4E (0.72) KDM4EMAPTKMT2AMEN1ALOX15
SCHEMBL5078984 0.62 KDM4E (0.39) KDM4EMAPTKMT2AMEN1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002341-A1 METHODS OF MAKING NICOTINIC ACID DERIVATIVES AURORIUM HOLDINGS LLC 2024-01-04 US disclosed
CN-116635369-A Process for preparing nicotinic acid derivatives 弗特鲁斯控股有限责任公司 2023-08-22 CN disclosed
WO-2022087373-A1 METHODS OF MAKING NICOTINIC ACID DERIVATIVES VERTELLUS HOLDINGS LLC (US) 2022-04-28 WO disclosed
WO-2022087373-A1 METHODS OF MAKING NICOTINIC ACID DERIVATIVES VERTELLUS HOLDINGS LLC (US) 2022-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002341-A1 METHODS OF MAKING NICOTINIC ACID DERIVATIVES NAPRT, NNMT, NAMPT KDM4E 2875/4885MAPT 1698/4885KMT2A 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.